|
2024
|
Invention
|
Estrogen receptor-modulating compounds.
Described herein are compounds that are estrogen recepto... |
|
2023
|
Invention
|
Methods for treating cancer.
Disclosed herein are methods of treating one or more tumors by admi... |
|
|
Invention
|
Methods for treating cancer.
Disclosed herein are methods of inhibiting tumor growth or producin... |
|
|
Invention
|
Polymorphic forms of rad1901-2hcl.
Various polymorphic forms of RAD1901-2HCl, including three cr... |
|
2022
|
Invention
|
Methods for treating ovarian cancer.
Methods of treating ovarian cancer are disclosed. |
|
|
Invention
|
Estrogen receptor-modulating compounds. Described herein are compounds that are estrogen receptor... |
|
|
Invention
|
Animal model having homologous recombination of mouse pth1 receptor.
New transgenic non-human an... |
|
|
Invention
|
Animal model having homologous recombination of mouse pth1 receptor. New transgenic non-human ani... |
|
2021
|
Invention
|
Stable cannabinoid formulations.
The present invention is generally directed to substantially pu... |
|
|
Invention
|
Methods for treating cancer. Disclosed herein are methods of treating one or more tumors by admin... |
|
|
Invention
|
Polymorphic forms of rad1901-2hcl. Various polymorphic forms of RAD1901-2HCl, including three cry... |
|
2020
|
Invention
|
Methods for treating cancer. Disclosed herein are methods of inhibiting tumor growth or producing... |
|
|
Invention
|
Processes and compounds.
Useful processes of preparation and intermediates useful for the prepar... |
|
|
Invention
|
Processes and compounds. Useful processes of preparation and intermediates useful for the prepara... |
|
2019
|
Invention
|
Methods for treating cancer in models harboring esr1 mutations.
Disclosed herein are methods of ... |
|
|
Invention
|
Methods for treating cancer resistant to cdk4/6 inhibitors.
Disclosed herein are methods of trea... |
|
|
Invention
|
Methods for treating cancer in models harboring esr1 mutations. 1222 is R or Q. In some embodimen... |
|
|
Invention
|
Methods for treating cancer in models harboring esr1 mutations. Disclosed herein are methods of t... |
|
|
Invention
|
Methods for treating cancer resistant to cdk4/6 inhibitors. Disclosed herein are methods of treat... |
|
|
Invention
|
Methods for treating cancer resistant to cdk4/6 inhibitors. 12122 is R or Q. In some embodiments,... |
|
|
Invention
|
Elacestrant in combination with abemaciclib in women with breast cancer. The present disclosure r... |
|
|
Invention
|
Polymorphic forms of rad1901-2hcl. A solid form of RAD1901-2HCl having an X-ray powder diffractio... |
|
|
Invention
|
Polymorphic forms of rad 1901-2hcl. Various polymorphic forms of RAD1901-2HCI, including four cry... |
|
|
Invention
|
Polymorphic forms of rad1901-2hcl. Various polymorphic forms of RAD1901-2HCI, including four crys... |
|
2017
|
Invention
|
Methods for treating ovarian cancer. Methods of treating ovarian cancer are disclosed. |
|
|
Invention
|
Stable cannabinoid formulations. The present invention is generally directed to substantial... |
|
|
Invention
|
Stable cannabinoid formulations. The present invention is generally directed to substantially pur... |
|
2016
|
Invention
|
Combinations of rad1901 and a cdk 4/6 inhibitor for treating cancer. Disclosed herein are methods... |
